CDH11 and breast cancer: Kaplan-Meier survival analyses showed that both high CDH11 and ILF3 were significantly associated with a poor distant metastasis-free survival (DMSF) rate for breast cancer patients (Figure 8C, P = 0.014 and 0.023, respectively), and high expression of HOXC8 may also be associated with poor DMSF (P = 0.064).